LIFECORE BIOMEDICAL, INC. Gain (Loss) on Termination of Lease
LIFECORE BIOMEDICAL, INC. (LFCR) reported Gain (Loss) on Termination of Lease of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-08-05
- LIFECORE BIOMEDICAL, INC. gain (loss) on termination of lease for the quarter ending 2025-02-23 was $2.64M.
- LIFECORE BIOMEDICAL, INC. gain (loss) on termination of lease for fiscal 2025 was $2.64M.
- LIFECORE BIOMEDICAL, INC. gain (loss) on termination of lease for fiscal 2024 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 7 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $0.00 10-KT · filed 2026-03-16 | |||
| 2025-05-25 | $2.64M 10-KT · filed 2026-03-16 | |||
| 2025-02-23 | $2.64M 10-Q · filed 2026-08-05 | |||
| 2024-05-26 | $0.00 10-KT · filed 2026-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |